When I entered into dermatology more than six years ago, I was immediately welcomed by a close-knit community of healthcare providers with a deep passion for partnering together with industry to address the needs of people living with dermatological conditions. In my current role as Head of U.S. Dermatology at UCB, I am honored to liaise with physicians, patients and my industry partners to better solve unmet needs and move forward the understanding of psoriatic conditions.
Since joining UCB, I’ve had the opportunity to leverage my training, my creativity and my passion to advance the dialogue around how we assess patient needs. When UCB began its focus in psoriatic disease years ago, while there were effective treatments on the market, the choices available were fairly limited and didn’t work for everyone. With new innovations, we’ve seen treatment options broaden dramatically. This is a testament to the work we do here at UCB – and the work of so many others in dermatology.
Unmet needs in immuno-dermatology still continue today, and UCB is committed to solving for these. We need to be thoughtful in the way we continue to innovate, requiring us to work with physicians and patients to pinpoint areas where improvements can be made.
